Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (NASDAQ:SLP), a leading provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, today announced that it has completed the molecule design phase of its second NCE (new chemical entity) project, and is issuing requests for quotes to synthesize the new compounds for testing. This second NCE project follows the Company’s successful project that was completed last year to design new molecules to inhibit the malaria parasite.
Help employers find you! Check out all the jobs and post your resume.
